In the US, Iodamide is a member of the drug class ionic iodinated contrast media.
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
V08AA03
CAS registry number (Chemical Abstracts Service)
0000440-58-4
Chemical Formula
C12-H11-I3-N2-O4
Molecular Weight
627
Therapeutic Category
Contrast medium
Chemical Name
Benzoic acid, 3-(acetylamino)-5-[(acetylamino)methyl]-2,4,6-triiodo-
Foreign Names
- Iodamidum (Latin)
- Iodamid (German)
- Iodamide (French)
- Iodamida (Spanish)
Generic Names
- Iodamide (OS: BAN, JAN, USAN, DCIT, DCF)
- Ametriodinic acid (IS)
- SH 926 (IS)
- Iodamide (PH: JP XIV)
- Meglumine Sodium Iodamide Injection (OS: JAN)
- Meglumine Sodium Iodamide Injection (PH: JP XIV)
- Iodamide Meglumine (OS: USAN)
- Meglumine Iodamide Injection (OS: JAN)
- Iodamide, comp. with N-methylglucamine (IS)
- Radiomiro (IS)
- Rayomiro (IS)
- Triomiro (IS)
Brand Names
- Angiomiron
Schering, Peru - Uromiron
Schering, Colombia; Schering, Peru
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment